Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05182931
Title A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) (I-FIRST)
Acronym I-FIRST
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Olivia Newton-John Cancer Research Institute
Age Groups: adult | senior
Covered Countries AUS

Additional content available in CKB BOOST